- Home
- INSG vs BIOA Comparison
INSG vs BIOA Comparison
Compare INSG & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- BIOA
- Stock Information
- Founded
- INSG 1996
- BIOA 2015
- Country
- INSG United States
- BIOA United States
- Employees
- INSG N/A
- BIOA N/A
- Industry
- INSG Telecommunications Equipment
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- INSG Telecommunications
- BIOA Health Care
- Exchange
- INSG Nasdaq
- BIOA Nasdaq
- Market Cap
- INSG 129.5M
- BIOA 155.2M
- IPO Year
- INSG 2000
- BIOA 2024
- Fundamental
- Price
- INSG $13.01
- BIOA $5.09
- Analyst Decision
- INSG Buy
- BIOA Hold
- Analyst Count
- INSG 3
- BIOA 4
- Target Price
- INSG $13.00
- BIOA $5.67
- AVG Volume (30 Days)
- INSG 377.9K
- BIOA 153.9K
- Earning Date
- INSG 08-07-2025
- BIOA 11-06-2025
- Dividend Yield
- INSG N/A
- BIOA N/A
- EPS Growth
- INSG N/A
- BIOA N/A
- EPS
- INSG 0.28
- BIOA N/A
- Revenue
- INSG $174,015,000.00
- BIOA $3,863,000.00
- Revenue This Year
- INSG N/A
- BIOA N/A
- Revenue Next Year
- INSG $16.28
- BIOA N/A
- P/E Ratio
- INSG $46.73
- BIOA N/A
- Revenue Growth
- INSG 4.58
- BIOA N/A
- 52 Week Low
- INSG $6.24
- BIOA $2.88
- 52 Week High
- INSG $20.67
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- INSG 78.08
- BIOA 65.85
- Support Level
- INSG $11.88
- BIOA $4.55
- Resistance Level
- INSG $13.80
- BIOA $4.94
- Average True Range (ATR)
- INSG 0.91
- BIOA 0.20
- MACD
- INSG 0.18
- BIOA 0.04
- Stochastic Oscillator
- INSG 82.05
- BIOA 98.61
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.